110 related articles for article (PubMed ID: 8862894)
21. Mutation of beta-catenin gene in endometrial cancer but not in associated hyperplasia.
Ashihara K; Saito T; Mizumoto H; Nishimura M; Tanaka R; Kudo R
Med Electron Microsc; 2002 Mar; 35(1):9-15. PubMed ID: 12111402
[TBL] [Abstract][Full Text] [Related]
22. Assessment of the quality and frequency of mutations occurrence in PTEN gene in endometrial carcinomas and hyperplasias.
Konopka B; Paszko Z; Janiec-Jankowska A; Goluda M
Cancer Lett; 2002 Apr; 178(1):43-51. PubMed ID: 11849740
[TBL] [Abstract][Full Text] [Related]
23. Abnormal mismatch repair and other clinicopathologic predictors of poor response to progestin treatment in young women with endometrial complex atypical hyperplasia and well-differentiated endometrial adenocarcinoma: a consecutive case series.
Zakhour M; Cohen JG; Gibson A; Walts AE; Karimian B; Baltayan A; Aoyama C; Garcia L; Dhaliwal SK; Elashoff D; Amneus M; Walsh C
BJOG; 2017 Sep; 124(10):1576-1583. PubMed ID: 28128512
[TBL] [Abstract][Full Text] [Related]
24. Detection of genomic alterations in human endometrial cancer by two-dimensional gel electrophoresis.
Pohlod-Miller S; Fanning J; Gu P; Crist KA; You M
Am J Obstet Gynecol; 2002 May; 186(5):855-7. PubMed ID: 12015494
[TBL] [Abstract][Full Text] [Related]
25. Mutational analysis of the PTEN gene in endometrial carcinoma and hyperplasia.
Sun H; Enomoto T; Fujita M; Wada H; Yoshino K; Ozaki K; Nakamura T; Murata Y
Am J Clin Pathol; 2001 Jan; 115(1):32-8. PubMed ID: 11190805
[TBL] [Abstract][Full Text] [Related]
26. Neural precursor cell-expressed developmentally down-regulated 4-like: a new biomarker in the pathophysiology of endometrial cancer.
Yilmaz E; Gul M; Melekoglu R; Inci Coskun E; Sahin N; Gul S; Bastemur AG; Ciplak B
J Int Med Res; 2018 Sep; 46(9):3709-3716. PubMed ID: 29998764
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical staining of GLUT1 in benign, hyperplastic, and malignant endometrial epithelia.
Wang BY; Kalir T; Sabo E; Sherman DE; Cohen C; Burstein DE
Cancer; 2000 Jun; 88(12):2774-81. PubMed ID: 10870060
[TBL] [Abstract][Full Text] [Related]
28. Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma.
Sasaki H; Nishii H; Takahashi H; Tada A; Furusato M; Terashima Y; Siegal GP; Parker SL; Kohler MF; Berchuck A
Cancer Res; 1993 Apr; 53(8):1906-10. PubMed ID: 8467512
[TBL] [Abstract][Full Text] [Related]
29. Genetic alterations in endometrial hyperplasia and cancer.
Fabjani G; Kucera E; Schuster E; Minai-Pour M; Czerwenka K; Sliutz G; Leodolter S; Reiner A; Zeillinger R
Cancer Lett; 2002 Jan; 175(2):205-11. PubMed ID: 11741749
[TBL] [Abstract][Full Text] [Related]
30. A polymerase chain reaction assay for non-random X chromosome inactivation identifies monoclonal endometrial cancers and precancers.
Mutter GL; Chaponot ML; Fletcher JA
Am J Pathol; 1995 Feb; 146(2):501-8. PubMed ID: 7856759
[TBL] [Abstract][Full Text] [Related]
31. [Introduction to molecular biology of endometrial cancer].
Esteller M; Reventós J
Med Clin (Barc); 1996 Jun; 107(5):175-7. PubMed ID: 8758676
[No Abstract] [Full Text] [Related]
32. [Microsatellites instability--actuality and clinical significance in hyperplastic processes and endometrium neoplasm (review of literature)].
Makarov OV; Patrushev LI; Ignatchenko OIu; Ozolinia LA; Dzhobava EM
Klin Lab Diagn; 2001 Dec; (12):16-22. PubMed ID: 11840823
[No Abstract] [Full Text] [Related]
33. Mutations and amplification of oncogenes in endometrial cancer.
Niederacher D; An HX; Cho YJ; Hantschmann P; Bender HG; Beckmann MW
Oncology; 1999; 56(1):59-65. PubMed ID: 9885379
[TBL] [Abstract][Full Text] [Related]
34. Genes involved in DNA repair are mutational targets in endometrial cancers with microsatellite instability.
Vassileva V; Millar A; Briollais L; Chapman W; Bapat B
Cancer Res; 2002 Jul; 62(14):4095-9. PubMed ID: 12124347
[TBL] [Abstract][Full Text] [Related]
35. BRAF mutation in endometrial carcinoma and hyperplasia: correlation with KRAS and p53 mutations and mismatch repair protein expression.
Feng YZ; Shiozawa T; Miyamoto T; Kashima H; Kurai M; Suzuki A; Konishi I
Clin Cancer Res; 2005 Sep; 11(17):6133-8. PubMed ID: 16144912
[TBL] [Abstract][Full Text] [Related]
36. PTEN sequence analysis in endometrial hyperplasia and endometrial carcinoma in Slovak women.
Gbelcová H; Bakeš P; Priščáková P; Šišovský V; Hojsíková I; Straka Ľ; Konečný M; Markus J; D'Acunto CW; Ruml T; Böhmer D; Danihel Ľ; Repiská V
Anal Cell Pathol (Amst); 2015; 2015():746856. PubMed ID: 26114084
[TBL] [Abstract][Full Text] [Related]
37. MLH1 and MSH2 protein expression as a pre-screening marker in hereditary and non-hereditary endometrial hyperplasia and cancer.
Berends MJ; Hollema H; Wu Y; van Der Sluis T; Mensink RG; ten Hoor KA; Sijmons RH; de Vries EG; Pras E; Mourits MJ; Hofstra RM; Buys CH; Kleibeuker JH; van Der Zee AG
Int J Cancer; 2001 May; 92(3):398-403. PubMed ID: 11291077
[TBL] [Abstract][Full Text] [Related]
38. [KRAS mutations analysis in mucinous epithelial lesions of the endometrium].
Zheng XZ; Zhan Y; Ma JH; Xu HW; Zhi WX; Chen TB; Qin XY; Wang P; Zhang LH; Gu YC; Jin YL; Zhu L; Wu BQ
Zhonghua Bing Li Xue Za Zhi; 2018 Sep; 47(9):687-690. PubMed ID: 30220122
[No Abstract] [Full Text] [Related]
39. Strong correlation between molecular changes in endometrial carcinomas and concomitant hyperplasia.
Zauber P; Denehy TR; Taylor RR; Ongcapin EH; Marotta S; Sabbath-Solitare M
Int J Gynecol Cancer; 2015 Jun; 25(5):863-8. PubMed ID: 25768080
[TBL] [Abstract][Full Text] [Related]
40. The role of hepatocyte growth factor activator inhibitor (HAI)-1 and HAI-2 in endometrial cancer.
Nakamura K; Hongo A; Kodama J; Hiramatsu Y
Int J Cancer; 2011 Jun; 128(11):2613-24. PubMed ID: 20715109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
